Overview
Sponsor-declared trial summary
Phase
Human pharmacology (Phase I) - Other
Status
Ongoing, recruiting
Participants planned
30
Countries
1
Sites
1
alopecia areata
Key facts
- Sponsor
- Sun Pharmaceutical Industries Inc.
- Participant type
- Healthy volunteers
- Age range
- 18-64 years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Immune System Diseases [C20]
- Trial duration
- 19 Nov 2025 → ongoing
- Decision date (initial)
- 2025-10-27
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- Yes
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
alopecia areata
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
Sun Pharmaceutical Industries Inc.
- Sponsor organisation
- Sun Pharmaceutical Industries Inc.
- Address
- 99 Hayden Avenue Suite 400
- City
- Lexington
- Postcode
- 02421-7966
- Country
- United States
Scientific contact point
- Organisation
- Sun Pharmaceutical Industries Inc.
- Contact name
- Vera Cigler
Public contact point
- Organisation
- Sun Pharmaceutical Industries Inc.
- Contact name
- Vera Cigler
Locations
1 EU/EEA country · 1 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Romania | Ongoing, recruiting | 30 | 1 |
| Rest of world | — | 0 | — |
Investigational sites
Terapia S.A.
CPP Department, Strada Fabricii Nr. 124, 400640, Cluj-Napoca
Country notifications
Trial-start, recruitment-start, end and early-termination notifications submitted per Member State
| Country | Trial start | Trial end | Recruitment start | Recruitment end | Early termination |
|---|---|---|---|---|---|
| Romania | 2025-11-19 | 2025-11-20 |
Application history
1 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2025-06-30 | Romania | No conclusion 2025-10-20
|
2025-10-27 |